Charmacy Pharmaceutical Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	48.28	53.28	51.34	90.47	23.15	40.56
Depreciation & Amortization	29.34	29.75	26.47	30.68	32.03	24.55
Other Amortization	7.66	6.27	2.95	2.89	1.73	0.81
Loss (Gain) From Sale of Assets	0.08	-0.31	-0.05	-65.84	-0.15	-0.02
Asset Writedown & Restructuring Costs	0.2	0.36	-0.01	-	0.01	-
Loss (Gain) From Sale of Investments	-	-	0.1	-	-0	-
Provision & Write-off of Bad Debts	-0.5	0.07	0.8	2.48	-0.29	11.37
Other Operating Activities	38.15	38.14	41.16	36.31	41.71	36.17
Change in Accounts Receivable	2,647	-409.63	-98.17	-222.47	-54.81	-158.03
Change in Inventory	67.21	116.04	-193.35	-77.74	75.75	-69.82
Change in Accounts Payable	-2,580	272.54	72.25	245.77	-139.9	248.47
Operating Cash Flow	256.1	106.04	-96.54	44.05	-19.54	131.08
Operating Cash Flow Growth	-	-	-	-	-	3161.49%
Capital Expenditures	-9.31	-15.73	-40.85	-8.59	-25.04	-51.98
Sale of Property, Plant & Equipment	0.05	0.08	80.19	80.35	0.64	0.06
Cash Acquisitions	-	-	-	-	-	-2.86
Other Investing Activities	-	-	-	-	0	-
Investing Cash Flow	-9.26	-15.64	39.34	71.76	-24.4	-54.78
Short-Term Debt Issued	-	3,688	2,492	2,852	1,807	1,561
Long-Term Debt Issued	-	1,266	836.6	2.26	974.03	957.63
Total Debt Issued	5,185	4,955	3,329	2,855	2,781	2,518
Short-Term Debt Repaid	-	-3,883	-2,388	-3,017	-1,830	-1,576
Long-Term Debt Repaid	-	-1,038	-767.41	-3.58	-824.11	-888.63
Total Debt Repaid	-5,082	-4,921	-3,156	-3,021	-2,654	-2,465
Net Debt Issued (Repaid)	102.13	33.98	172.72	-166.48	126.33	53.65
Common Dividends Paid	-65.58	-64.2	-75.5	-28.44	-52.49	-56.51
Other Financing Activities	-201.72	-1.31	4.04	3.71	0.56	0.18
Financing Cash Flow	-165.18	-31.54	101.26	-191.21	74.4	-2.68
Foreign Exchange Rate Adjustments	-0	0.01	0.01	0.03	-	0
Net Cash Flow	81.66	58.87	44.07	-75.37	30.46	73.62
Free Cash Flow	246.78	90.31	-137.39	35.46	-44.58	79.1
Free Cash Flow Margin	5.82%	2.04%	-3.12%	0.85%	-1.18%	1.98%
Free Cash Flow Per Share	2.29	0.84	-1.27	0.33	-0.41	0.73
Cash Income Tax Paid	49.82	52.98	58.86	36.02	37.42	26.93
Levered Free Cash Flow	-56.44	-69.75	10.27	-145.91	-28.06	-12.53
Unlevered Free Cash Flow	-18.68	-30.71	36.48	-123.99	-2.12	7.31
Change in Working Capital	132.88	-21.53	-219.31	-52.94	-117.74	17.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.